Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
180 Life Sciences (ATNF)
NASDAQ:ATNF
180 Life Sciences (ATNF) Stock Price & Analysis
181 Followers
ATNF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.18 - $71.40
Previous Close$3.24
Volume954.65K
Average Volume (3M)4.34M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-0.4
Beta1.71
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-7.72
Shares Outstanding24,400,000
R-Squared0.02
Standard Deviation0.95
10 Day Avg. Volume2,593,697
30 Day Avg. Volume4,344,881
Price to Book (P/B)-6.87
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Alpha0.11
Number of Analyst Covering0
180 Life Sciences News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ATNF FAQ
What was 180 Life Sciences’s price range in the past 12 months?
180 Life Sciences lowest stock price was $1.18 and its highest was $71.40 in the past 12 months.
What is 180 Life Sciences’s market cap?
Currently, no data Available
When is 180 Life Sciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were 180 Life Sciences’s earnings last quarter?
Currently, no data Available
Is 180 Life Sciences overvalued?
According to Wall Street analysts 180 Life Sciences’s price is currently Overvalued.
Does 180 Life Sciences pay dividends?
180 Life Sciences does not currently pay dividends.
What is 180 Life Sciences’s EPS estimate?
180 Life Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 180 Life Sciences have?
180 Life Sciences has 2,238,025 shares outstanding.
What happened to 180 Life Sciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of 180 Life Sciences?
Currently, no hedge funds are holding shares in ATNF
---
180 Life Sciences Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.8%
Last 30 Days ▲ 39.5%
Last 30 Days ▲ 39.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-93.67%
12-Months-Change
Fundamentals
Return on Equity
-50.45%
Trailing 12-Months
Asset Growth
-47.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
180 Life Sciences
KBL Merger Corp. IV is a blank check company, which focuses on acquiring an operating company in the healthcare and related wellness industry. The company was founded on September 7, 2016 and is headquartered in Newark, DE.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
Catalyst Biosciences
―
eFFECTOR Therapeutics
―
Immix Biopharma, Inc.
―
Cellectar Biosciences
―
---